Clinical Trial Update: Efficacy of LAMA Added to ICS in Treatment of Asthma (ELITRA) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the efficacy of adding a long-acting muscarinic antagonist to inhaled corticosteroids for asthma; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• LAMA add-on to inhaled corticosteroids

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2026-04-22